Based on the updated valuation , mwb research AG sets the target price for the GEVORKYAN share at EUR 12.80, which implies an upside potential of approximately 68 % compared to the market price at the time of the analysis(GEVORKYAN – Italian acquisition closed, BUY, 29 April 2026).
GEVORKYAN, a.s. announces an update of the independent analyst coverage of its shares.
On 29 April 2026, mwb research AG published its analysis following the completion of the acquisition of the Italian company Gevorkyan Sinteris Italia: ResearchHub: Gevorkyan, Inc.
According to the analytical report, GEVORKYAN, a.s. should achieve revenues of EUR 99.6 million (+18.5% year-on-year) and EBITDA of EUR 33.3 million (+18.5%) in 2026. The target share price is EUR 12,80, which implies a growth potential of 68,1 % compared to the current market price of EUR 7,61 at the time of the analysis. GEVORKYAN, Inc. has been assigned aBUYinvestment recommendation, reflecting a combination of strong profitability (EBITDA margin of 33.4%), double-digit revenue growth and the company’s strengthening technology position, according to the analysis.
About GEVORKYAN, a.s.
GEVORKYAN, a.s. is a leading European powder metallurgy company, a global supplier to large multinational companies and one of the world’s most innovative companies in this sector. For more information, please visit https://www.gevorkyan.eu/
About mwb research AG
mwb research AG, based in Hamburg, is an independent German research company providing investment research and evaluation of European issuers. Analyses are published via platforms such as Bloomberg, FactSet and ResearchHub. For more information, please visit www.mwb-research.com.
Contact information:
Financial Affairs: Andrej Bátovský, andrej.batovsky@gevorkyan.sk
Media: Alexandra Hazuchová, marketing@gevorkyan.sk
Please note:
This press release refers to an independent analytical report prepared by mwb research AG. The recommendations and price estimates reflect the independent opinion of the analyst and do not constitute an investment recommendation by GEVORKYAN, Inc. The Company is not responsible for the content or conclusions of the above analyst report.